IQVIA Inc. (IQV)
NYSE: IQV
· Real-Time Price · USD
187.76
3.68 (2.00%)
At close: Sep 05, 2025, 3:59 PM
187.68
-0.04%
After-hours: Sep 05, 2025, 06:09 PM EDT
IQVIA Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Sales And Medical Solutions Revenue | 181M | 177M | 180M | 172M | 189M | 186M | 183M | 176M | 182M | 182M | 183M | 183M | 195M | 196M | 201M | 194M | 193M | 189M | 179M | 177M | 196M | 52M | 48M | 49M | 51M | 52M | 56M | 59M | 1.36B | 947M | 938M | 896M | 866M |
| Contract Sales And Medical Solutions Revenue Growth | +2.26% | -1.67% | +4.65% | -8.99% | +1.61% | +1.64% | +3.98% | -3.30% | 0.00% | -0.55% | 0.00% | -6.15% | -0.51% | -2.49% | +3.61% | +0.52% | +2.12% | +5.59% | +1.13% | -9.69% | +276.92% | +8.33% | -2.04% | -3.92% | -1.92% | -7.14% | -5.08% | -95.68% | +44.14% | +0.96% | +4.69% | +3.46% | n/a |
| Research And Development Solutions Revenue | 2.1B | 2.12B | 2.16B | 2.15B | 2.1B | 2.15B | 2.12B | 2.1B | 2.03B | 2.06B | 1.98B | 1.95B | 1.93B | 1.94B | 1.85B | 1.89B | 1.87B | 1.68B | 1.4B | 1.24B | 1.44B | 436M | 394M | 448M | 456M | 310M | 418M | 414M | n/a | n/a | n/a | n/a | n/a |
| Research And Development Solutions Revenue Growth | -0.99% | -1.80% | +0.70% | +2.48% | -2.60% | +1.37% | +1.24% | +3.46% | -1.55% | +3.99% | +1.49% | +0.83% | -0.51% | +4.91% | -2.01% | +1.23% | +10.93% | +20.29% | +13.36% | -14.30% | +230.50% | +10.66% | -12.05% | -1.75% | +47.10% | -25.84% | +0.97% | n/a | n/a | n/a | n/a | n/a | n/a |
| Technology And Analytics Solutions Revenue | 1.55B | 1.66B | 1.55B | 1.5B | 1.45B | 1.53B | 1.43B | 1.46B | 1.44B | 1.5B | 1.4B | 1.41B | 1.44B | 1.5B | 1.34B | 1.35B | 1.35B | 1.43B | 1.21B | 1.11B | 1.12B | 415M | 369M | 376M | 383M | 137M | 359M | 374M | n/a | n/a | n/a | n/a | n/a |
| Technology And Analytics Solutions Revenue Growth | -6.76% | +6.69% | +3.95% | +2.89% | -5.09% | +6.99% | -1.72% | +0.83% | -3.67% | +7.07% | -0.57% | -2.15% | -3.81% | +11.89% | -1.18% | +0.37% | -5.40% | +18.06% | +8.84% | -0.72% | +169.16% | +12.47% | -1.86% | -1.83% | +179.56% | -61.84% | -4.01% | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|
| Americas Revenue | 1.81B | 1.85B | 1.84B | 1.86B | 1.8B | 1.86B | 1.17B |
| Americas Revenue Growth | -2.48% | +0.82% | -1.34% | +3.39% | -2.91% | +58.36% | n/a |
| Asia Pacific Revenue | 798M | 807M | 771M | 773M | 778M | 791M | 501M |
| Asia Pacific Revenue Growth | -1.12% | +4.67% | -0.26% | -0.64% | -1.64% | +57.88% | n/a |
| Emea Revenue | 1.22B | 1.3B | 1.29B | 1.18B | 1.16B | 1.09B | 890M |
| Emea Revenue Growth | -5.70% | +0.85% | +9.25% | +1.82% | +6.24% | +22.36% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 509M | 508M | 453M | 522M | 509M | 508M | 556M | 502M | 482M | 513M | 583M | 517M | 483M | 488M | 542M | 498M | 482M | 442M | 491M | 460M | 431M | 407M | 484M | 395M | 436M | 419M | 443M | 429M | 424M | 420M | 464M | 391M | 370M | 380M | 390M | 233.65M | 250.57M | 225.52M | 244.07M | 231.41M | 225.9M | 219.61M |
| Selling, General, and Administrative Revenue Growth | +0.20% | +12.14% | -13.22% | +2.55% | +0.20% | -8.63% | +10.76% | +4.15% | -6.04% | -12.01% | +12.77% | +7.04% | -1.02% | -9.96% | +8.84% | +3.32% | +9.05% | -9.98% | +6.74% | +6.73% | +5.90% | -15.91% | +22.53% | -9.40% | +4.06% | -5.42% | +3.26% | +1.18% | +0.95% | -9.48% | +18.67% | +5.68% | -2.63% | -2.56% | +66.92% | -6.75% | +11.11% | -7.60% | +5.47% | +2.44% | +2.87% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |